Literature DB >> 6620299

Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetylcolchicines.

A Brossi, P N Sharma, L Atwell, A E Jacobson, M A Iorio, M Molinari, C F Chignell.   

Abstract

A series of natural and synthetic colchicine derivatives was examined for their potency in the lymphocytic leukemia P388 screen in mice, for their toxicity in mice, and for their binding to microtubule protein. The natural alkaloids cornigerine and colchifoline and several N,O-substituted analogues of colchifoline were found to be as potent and as toxic as colchicine in the P388 screen with good affinity for tubulin. The 1,2-(methylenedioxy)-substituted isomer of cornigerine was considerably less potent in vivo than could have been anticipated from the in vitro tubulin binding data. Several N-acyl and N-aroyl derivatives prepared from deacetylcolchicine showed high potency in the in vitro and in vivo screens. Colchicide was found to be highly potent in vivo, and N-carbethoxydeacetylcolchicine, a synthetic analogue of colchicine with a N-carbethoxy instead of an N-acetyl function, showed interesting biological properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620299     DOI: 10.1021/jm00364a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Mechanism of tubulin-colchicine recognition: a kinetic study of the binding of the colchicine analogues colchicide and isocolchicine.

Authors:  C Dumortier; Q Yan; S Bane; Y Engelborghs
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.

Authors:  Jin Zhang; Jing Zhou; Xiaomei Ren; Yanyan Diao; Honglin Li; Hualiang Jiang; Ke Ding; Duanqing Pei
Journal:  Invest New Drugs       Date:  2010-11-16       Impact factor: 3.850

3.  B ring regulation of colchicine binding kinetics and fluorescence.

Authors:  B Bhattacharyya; R Howard; S N Maity; A Brossi; P N Sharma; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy.

Authors:  Bart J Crielaard; Steffen van der Wal; Twan Lammers; Huong Thu Le; Wim E Hennink; Raymond M Schiffelers; Gert Storm; Marcel Ham Fens
Journal:  Int J Nanomedicine       Date:  2011-11-02

5.  Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide.

Authors:  Kelsey E Knewtson; Chamani Perera; David Hymel; Zhe Gao; Molly M Lee; Blake R Peterson
Journal:  ACS Omega       Date:  2019-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.